Review Article

Preclinical Studies and Translational Applications of Intracerebral Hemorrhage

Table 3

Previous and current clinical trials.

Agent Name of studyResultTrial NumberTarget

MannitolNo significanceEdema [16]

rFVIIaFASTOngoingNCT00127283Hematoma regrowth [17]

FingolimodPhase 2NCT02002390Edema [18]

NXYO59CHANTNo significanceFree radical [19]

DeferoxamineDFO-ICHOngoingNCT02175225Iron chelation & perihematomal edema
NCT02367248

PioglitazoneSHRINCPhase 3NCT00827892PPARγ-agonist [20]

CelecoxibACE-ICHOngoingcyclooxygenase-2

HypertensionCHANTOngoingHematoma regrowth & BP control [20]
INTERACTCompletedHematoma regrowth & BP control [21]
ADAPTCompletedHematoma regrowth & BP control [22]
ATTACHNo significanceHematoma regrowth & BP control [23]

Stem cellOngoingNCT02065778
NCT02245698
NCT01832428
NCT01714167
Many targets [24]

ElectroacupunctureOngoingMany targets